1[1]Tanaka A, Borchers A T, Ishibashi H et al. Genetic and familial consider ations of primary biliary cirrhosis [ J ]. Am J Gastroenterol, 2001; 96 ( 1 ): 8 被引量：1
2[2]Kim W R, Lindor K D, Locke G R et al. Epidemiology and natural history of primary biliary cirrhosis in a US community[J]. Gastroenterology, 2000; 119(6): 1631 被引量：1
3[3]Miyakawa H, Tanaka A, Kikuchi K et al. High sensitivity of a novel ELISA for anti-M2 in primary biliary cirrhosis[J]. Hepatology, 2001; 34 (2) :243 被引量：1
4[4]Joplin R E, Neuberger J. Immunopathology of primary biliary cirrhosis [J]. Eur J Gastroenterol Hepatol, 1999; 11 (6) :587 被引量：1
5[5]Metcalf J V,Mitchison H C,Palmer J et al. Natural history of early pri mary biliary cirrhosis[J]. Lancet, 1996;348(8): 1399 被引量：1
6[6]Koizumi H, Onozuka Y, Shibata M et al. Positive rate of anti-mitochondri al antibody in Japanese corporate workers[J]. Rinsho Byori, 2000; 48 (10) :966 被引量：1
7[7]Jones D E J, Palmer J M, Kirby J A et al. Experimental autoimmune cholangitis: a mouse model of immune-mediated cholangiopathy[J]. Liver, 2000;20( 1 ): 351 被引量：1
8[8]Ahmed A F, Ohtani H, Nio M et al. CD8+ T cells infiltrating into bile ducts in biliary atresia do not appear to function as cytotoxic T cells: a clinicopathological analysis[J] .J Pathol,2001; 193(3) :383 被引量：1
9[9]Harada K, Ozaki S, Gershwin M E et al. Enhanced apoptosis relates to bile duct loss in primary biliary cirrhosis [J]. Hepatology, 1997; 26 (6): 1399 被引量：1
10[10]Sekiya H, Komats T,lsono E et al. Decrease in the prevalence of IL-4producing CD4+ T cells in patients with advanced stage of primary biliarycirrhosis[J]. Am J Gastroenterol, 1999 ;94(12): 3589 被引量：1
